Shane Mcmanus
Department of Management
pua venture resources GmbH
Austria
Biography
Shane previously served as Chief Scientific Officer at Akron Molecules AG, taking the company from start-up into phase II clinical development. He is experienced in preclinical and clinical development, fund raising, business development, operations, regulatory and IP strategy. He has worked in multiple therapeutic areas in both human and veterinary drug development and has specialist expertise in drug repurposing.
Research Interest
Clinical Research
